HBK Sorce Advisory LLC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 31 filers reported holding NRX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
HBK Sorce Advisory LLC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,600
-46.2%
29,2300.0%0.00%
-100.0%
Q2 2023$14,133
-26.6%
29,2300.0%0.00%0.0%
Q1 2023$19,266
+29540.0%
29,230
-50.0%
0.00%
-50.0%
Q4 2022$6558,4600.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders